Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018

BACKGROUND: A novel meningococcal serogroup A conjugate vaccine (MACV [MenAfriVac]) was developed as part of efforts to prevent frequent meningitis outbreaks in the African meningitis belt. The MACV was first used widely and with great success, beginning in December 2010, during initial deployment i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Infect Dis
Hlavní autoři: Bwaka, Ado, Bita, André, Lingani, Clément, Fernandez, Katya, Durupt, Antoine, Mwenda, Jason M, Mihigo, Richard, Djingarey, Mamoudou H, Ronveaux, Olivier, Preziosi, Marie-Pierre
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Supplement Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822965/
https://ncbi.nlm.nih.gov/pubmed/31671448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz336
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky